Beta-blockers and Personalized treatment of Hypertension: A Literature Review
β-blockers: Personalized medicine 30 to 60% of hypertensive patients who are on beta-blocker monotherapy fail to respond adequately. This variation in response is accounted for by a genetic polymorphism in the ADRB1 gene, which encodes the adrenergic beta-receptor type-1 to